Anti-Aging
Scientists in Japan and the United States plan to begin a joint clinical study in Japan to test the safety and effectiveness in humans of the compound NMN, that is gradually being proved to retard the aging process in animals.
Researchers at Keio University in Japan and Washington University in St. Louis are planning to begin a joint clinical study in Japan to test in humans the safety and effectiveness of a compound that is on the verge of being a proven to reverse the effects of aging. The clinical study is scheduled to begin as early as next month.
Related articles
David Sinclair was formerly associated with research of the compound, nicotinamide mononucleotide, or NMN. Sinclair has previously said the compound could lead to breakthroughs that could be used to develop drugs to restore youthfulness in human cells."We've confirmed a remarkable effect in the experiment using mice, but it's not clear yet how much [the compound] will affect humans"
NMN is a chemical compound produced within the bodies of many living things, including people. NMN is also contained in food products. An experiment using mice is gradually showing that this compound activates sirtuin, whose functions are weakened due to aging, improving such things as symptoms of diabetes
Now, Keio University's Research Ethics Committee will check the appropriateness of the plan and other factors. If approved, researchers plan to begin giving the NMN to about 10 healthy people to confirm its safety. They will then examine whether NMN can improve functions of the human body.
A research group including Professor Shinichiro Imai of Washington University, a gerontology expert, has confirmed that NMN activates sirtuin. An experiment giving NMN to mice found that the compound can reverse age-linked declines in metabolism and eyesight.
Imai has been studying molecular mechanisms of mammalian aging and longevity at cellular and organismal levels for decades and making significant contributions to the field of aging research. A video profile of Imai, who is working towards the Palo Alto Longevity Prize as well, is embedded below.
The study is planned to be conducted by researchers including Imai and Keio University, using NMN made by a Japanese producer
. The central government has decided to provide full-fledged support for anti-aging studies from next fiscal year, and is also paying attention to this clinical study."We've confirmed a remarkable effect in the experiment using mice, but it's not clear yet how much [the compound] will affect humans," Imai said. "We'll carefully conduct the study, which I hope will result in important findings originating in Japan."
0 comments:
Post a Comment